8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 1/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 2/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 3/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 4/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 5/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 6/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 7/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 8/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 9/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 10/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 11/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 12/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 13/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 14/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 15/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 16/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 17/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 18/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 19/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 20/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 21/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 22/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 23/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 24/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 25/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 26/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 27/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 28/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 29/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 30/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 31/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 32/33

8/20/2019 Guidelines for Monitoring and Reporting Adverse Drug Reactions (Adrs)

http://slidepdf.com/reader/full/guidelines-for-monitoring-and-reporting-adverse-drug-reactions-adrs 33/33